Insights

Industry Leadership Adimab is a leader in antibody discovery with over 600 discovery campaigns and more than 80 clinical programs, demonstrating strong market presence and proven success which can be leveraged for collaborative opportunities.

Innovative Technology The company's yeast-based platform for fully human monoclonal and bispecific antibody discovery positions it at the cutting edge of biotherapeutic development, creating potential for partnerships in advanced protein engineering.

Strategic Collaborations Adimab's active collaborations with major pharmaceutical companies, including Boehringer Ingelheim and Ono Pharmaceutical, offer avenues for joint R&D initiatives and licensing agreements.

Growth & Expansion Recent hires and product launches, such as heavy-chain antibody libraries, indicate ongoing growth and innovation, presenting opportunities to provide complementary services or technologies to support their development pipeline.

Financial Potential With annual revenues estimated between $50 million and $100 million and a robust client base, Adimab represents a strategic target for solutions that can enhance efficiency, scaleup, or novel antibody modalities.

Similar companies to Adimab

Sartorius Stedim Biotech
$250M$500M

Adimab Tech Stack

Adimab uses 8 technology products and services including Open Graph, Drupal, Apple iCloud Mail, and more. Explore Adimab's tech stack below.

Open Graph
Content Management System
Drupal
Content Management System
Apple iCloud Mail
Email
DocuSign
Miscellaneous
Netlify
Platform As A Service
HSTS
Security
Google Analytics
Web Analytics
Astra
Web Platform Extensions

Media & News

Adimab's Email Address Formats

Adimab uses at least 1 format(s):

Adimab Email Formats	Example	Percentage
First.Last@adimab.com	John.Doe@adimab.com	90%
Last@adimab.com	Doe@adimab.com	7%
First@adimab.com	John@adimab.com	2%
FLast@adimab.com	JDoe@adimab.com	1%

Frequently Asked Questions

Where is Adimab's headquarters located?

Adimab's main headquarters is located at 7 Lucent Drive, Lebanon, New Hampshire 03766, US. The company has employees across 2 continents, including North AmericaEurope.

What is Adimab's phone number?

You can contact Adimab's main corporate office by phone at

+1-603-643-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adimab's official website and social media links?

Adimab's official website is adimab.com and has social profiles on LinkedIn Crunchbase.

How much revenue does Adimab generate?

As of October 2025, Adimab's annual revenue is estimated to be $11M.

What is Adimab's SIC code NAICS code?

Adimab's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Adimab have currently?

As of October 2025, Adimab has approximately 140 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: P. C.Chief Executive Officer: T. G.Chief Business Officer: G. V. M.. Explore Adimab's employee directory with LeadIQ.

What industry does Adimab belong to?

Adimab operates in the Biotechnology Research industry.

What technology does Adimab use?

Adimab's tech stack includes Open GraphDrupalApple iCloud MailDocuSignNetlifyHSTSGoogle AnalyticsAstra.

What is Adimab's email format?

Adimab's email format typically follows the pattern of First.Last@adimab.com. Find more Adimab email formats with LeadIQ.

When was Adimab founded?

Adimab was founded in 2007.

Adimab

Biotechnology ResearchUnited States51-200 Employees

Adimab is the most successful antibody discovery company in the industry, with 600+ discovery campaigns and 80+ clinical programs created with more than 130 partners.

Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading academic institutions. 

We're committed to staying at the cutting edge of protein-based therapeutic discovery to enable the highest quality IgGs, multispecifics, CARs and other modalities to allow our partners to have the most successful therapeutic programs possible.

Company Overview

Headquarters: 7 Lucent Drive, Lebanon, New Hampshire 03766, US
Phone number: +1-603-643-****
Website: adimab.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2007
Employees: 51-200